Literature DB >> 15937291

Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema.

Andrew K Sullivan1, Philip L Simonian, Michael T Falta, John D Mitchell, Gregory P Cosgrove, Kevin K Brown, Brian L Kotzin, Norbert F Voelkel, Andrew P Fontenot.   

Abstract

RATIONALE: Within the lungs of patients with severe emphysema, inflammation continues despite smoking cessation. Foci of T lymphocytes in the small airways of patients with emphysema have been associated with disease severity. Whether these T cells play an important role in this continued inflammatory response is unknown.
OBJECTIVE: The aim of this study was to determine if T cells recruited to the lungs of subjects with severe emphysema contain oligoclonal T-cell populations, suggesting their accumulation in response to antigenic stimuli.
METHODS: Lung T-cell receptor (TCR) Vbeta repertoire from eight patients with severe emphysema and six control subjects was evaluated at the time of tissue procurement (ex vivo) and after 2 weeks of culture with interleukin 2 (in vitro). Junctional region nucleotide sequencing of expanded TCR-Vbeta subsets was performed.
RESULTS: No significantly expanded TCR-Vbeta subsets were identified in ex vivo samples. However, T cells grew from all emphysema (n = 8) but from only one of the control lung samples (n = 6) when exposed to interleukin 2 (p = 0.0013). Within the cultured cells, seven major CD4-expressing TCR-Vbeta subset expansions were identified from five of the patients with emphysema. These expansions were composed of oligoclonal populations of T cells that had already been expanded in vivo.
CONCLUSION: Severe emphysema is associated with inflammation involving T lymphocytes that are composed of oligoclonal CD4+ T cells. These T cells are accumulating in the lung secondary to conventional antigenic stimulation and are likely involved in the persistent pulmonary inflammation characteristic of severe emphysema.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937291      PMCID: PMC2718531          DOI: 10.1164/rccm.200410-1332OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  33 in total

1.  End-stage chronic obstructive pulmonary disease: the cigarette is burned out but inflammation rages on.

Authors:  S D Shapiro
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

2.  Amplification of inflammation in emphysema and its association with latent adenoviral infection.

Authors:  I Retamales; W M Elliott; B Meshi; H O Coxson; P D Pare; F C Sciurba; R M Rogers; S Hayashi; J C Hogg
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

Review 3.  Cellular and structural bases of chronic obstructive pulmonary disease.

Authors:  M Saetta; G Turato; P Maestrelli; C E Mapp; L M Fabbri
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

Review 4.  Inflammation of the airways and lung parenchyma in COPD: role of T cells.

Authors:  Manuel G Cosio; Joaquim Majo; Monica G Cosio
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

5.  Increased proportion of CD8+ T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPD.

Authors:  Marina Saetta; Simonetta Baraldo; Graziella Turato; Bianca Beghé; Gian Luca Casoni; Cinzia M Bellettato; Federico Rea; Renzo Zuin; Leonardo M Fabbri; Alberto Papi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2003-03       Impact factor: 0.670

6.  CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells.

Authors:  Andrew P Fontenot; Laia Gharavi; Sean R Bennett; Scott J Canavera; Lee S Newman; Brian L Kotzin
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

7.  Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung.

Authors:  Andrew P Fontenot; Lisa A Maier; Scott J Canavera; Tara B Hendry-Hofer; Mark Boguniewicz; Elizabeth A Barker; Lee S Newman; Brian L Kotzin
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

8.  Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.

Authors:  A P Fontenot; M Torres; W H Marshall; L S Newman; B L Kotzin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

9.  Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema.

Authors:  J Majo; H Ghezzo; M G Cosio
Journal:  Eur Respir J       Date:  2001-05       Impact factor: 16.671

10.  An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema.

Authors:  Sandra Grumelli; David B Corry; Li-Zhen Song; Ling Song; Linda Green; Joseph Huh; Joan Hacken; Rafael Espada; Remzi Bag; Dorothy E Lewis; Farrah Kheradmand
Journal:  PLoS Med       Date:  2004-10-19       Impact factor: 11.069

View more
  50 in total

Review 1.  How cigarette smoke skews immune responses to promote infection, lung disease and cancer.

Authors:  Martin R Stämpfli; Gary P Anderson
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

2.  Induction of pulmonary antibodies against oxidized lipids in mice exposed to cigarette smoke.

Authors:  Danya Thayaparan; Pamela Shen; Martin R Stämpfli; Mathieu C Morissette
Journal:  Respir Res       Date:  2016-08-04

3.  A Novel Animal Model of Emphysema Induced by Anti-Elastin Autoimmunity.

Authors:  Bon-Hee Gu; Maran L Sprouse; Matthew C Madison; Monica J Hong; Xiaoyi Yuan; Hui-Ying Tung; Cameron T Landers; Li-Zhen Song; David B Corry; Maria Bettini; Farrah Kheradmand
Journal:  J Immunol       Date:  2019-06-10       Impact factor: 5.422

Review 4.  Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

Authors:  Daniel J Hassett; Michael T Borchers; Ralph J Panos
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

Review 5.  The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research.

Authors:  Jeffrey L Curtis; Christine M Freeman; James C Hogg
Journal:  Proc Am Thorac Soc       Date:  2007-10-01

6.  High levels of lung resident CD4+CD28null cells in COPD: implications of autoimmunity.

Authors:  K Hoetzenecker; A Mitterbauer; E Guenova; T Schweiger; P Altmann; M Zimmermann; H Hofbauer; L Beer; W Klepetko; H J Ankersmit
Journal:  Wien Klin Wochenschr       Date:  2013-03-27       Impact factor: 1.704

Review 7.  Alveolar epithelial and endothelial cell apoptosis in emphysema: what we know and what we need to know.

Authors:  Mathieu C Morissette; Julie Parent; Julie Milot
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

8.  Human T cells stimulate fibroblast-mediated degradation of extracellular matrix in vitro.

Authors:  M Mikko; K Fredriksson; J Wahlström; P Eriksson; J Grunewald; C M Sköld
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

9.  Increased levels of (class switched) memory B cells in peripheral blood of current smokers.

Authors:  Corry-Anke Brandsma; Machteld N Hylkema; Marie Geerlings; Wouter H van Geffen; Dirkje S Postma; Wim Timens; Huib A M Kerstjens
Journal:  Respir Res       Date:  2009-11-12

10.  Eosinophil and T cell markers predict functional decline in COPD patients.

Authors:  Jeanine M D'Armiento; Steven M Scharf; Michael D Roth; John E Connett; Andrew Ghio; David Sternberg; Jonathan G Goldin; Thomas A Louis; Jenny T Mao; George T O'Connor; Joe W Ramsdell; Andrew L Ries; Neil W Schluger; Frank C Sciurba; Melissa A Skeans; Helen Voelker; Robert E Walter; Christine H Wendt; Gail G Weinmann; Robert A Wise; Robert F Foronjy
Journal:  Respir Res       Date:  2009-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.